NRD
MEDP icon

Nebula Research & Development’s Medpace MEDP Stock Holding History

Nebula Research & Development’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,849
Closed -$1.84M – 519
2025
Q2 		$1.84M Buy
5,849
+3,974
+212% +$1.19M 0.16% 214
2025
Q1 		$571K Sell
1,875
-457
-20% -$154K 0.05% 574
2024
Q4 		$775K Sell
2,332
-2,146
-48% -$728K 0.09% 389
2024
Q3 		$1.49M Buy
+4,478
New +$1.7M 0.18% 163

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nebula Research & Development's MEDP Position: Q3 2025 in Review

Nebula Research & Development sold out of Medpace (MEDP) in Q3 2025, closing a stake of 5,849 shares — an estimated $1.84M sold.

Nebula Research & Development first reported a position in MEDP in Q3 2024 and held it in 4 quarters. The position peaked at $1.84M in Q2 2025. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Nebula Research & Development reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 5,849 Medpace shares in Q3 2025, an estimated $1.84M.
  • Nebula Research & Development first reported a position in Medpace in Q3 2024 and held it in 4 quarters.
  • Nebula Research & Development's Medpace position peaked at $1.84M in Q2 2025.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.